Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 308430Orphan Drug37 approvals6 trials

Cellbion Co., Ltd

Official website

Cellbion develops Lu-177-Pocuvotide, a PSMA-targeted Theranostics drug for prostate cancer diagnosis and treatment.

As of 2026-10-11, Cellbion Co., Ltd has 36 Korean MFDS drug approvals, 6 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2010, Cellbion listed on KOSDAQ in 2024 as a radiopharmaceutical company. It supplies Cellbion Green Injection, Cellbion Mebrofenin Injection, and Dopa Tablet, while developing Lu-177-Pocuvotide, a PSMA-targeted Theranostics drug for prostate cancer diagnosis and treatment. Lu-177-Pocuvotide was selected as one of KDDF's top-10 national new drug development projects in 2023, received nonclinical and clinical R&D funding, and was designated an orphan drug in development and the 11th product under MFDS's Global Innovative product Fast Track (GIFT) program, completing domestic Phase 2 trials.

Products & technology

  • 셀비온그린주
  • 셀비온메브로페닌주
  • 도페정

Regulatory approvals

data.go.kr

1 Orphan Drug designations · 2021 / 36 Korean MFDS drug approvals · 2000–2025

  • OrphanPSMA-DGUL2021-12-27
    Orphan Drug designation · in development20210256037
  • MFDS drugEnticsa Tab. 5mg2025-12-15
    Drug · Prescription · Approval202503271
  • MFDS drugEnticsa Tab. 20mg2025-02-17
    Drug · Prescription · Approval202500341
  • MFDS drugCellbiongreen for injection2022-02-04
    Drug · Prescription · Notification202200558
  • MFDS drughumores solution2020-11-05
    Drug · OTC · Notification202007611
  • MFDS drugAreba Tab. 100mg2020-03-10
    Drug · Prescription · Approval202001633
  • MFDS drugN-talope Tab. 10mg2020-01-17
    Drug · Prescription · Approval202000260
  • MFDS drugNT-teride Tab. 5mg2020-01-14
    Drug · Prescription · Approval202000208
  • MFDS drug아세레캡슐200밀리그램(세레콕시브)2019-10-31
    Drug · Prescription · Approval201907649
  • MFDS drugAplon Tab. 4mg2019-10-22
    Drug · Prescription · Approval201907400
  • MFDS drugNT-ome Tab. 20mg2019-10-04
    Drug · Prescription · Approval201907046
  • MFDS drugNT-ome Tab. 40mg2019-10-04
    Drug · Prescription · Approval201907047
Show 25 more
  • MFDS drugEnticsa Tab. 10mg2019-10-04
    Drug · Prescription · Approval201907050
  • MFDS drug아뮤렉정50밀리그램(에페리손염산염)2019-10-02
    Drug · Prescription · Approval201907018
  • MFDS drugNT-cerein Cap. 50mg2019-09-30
    Drug · Prescription · Approval201906906
  • MFDS drug아발린캡슐150밀리그램(프레가발린)2019-09-26
    Drug · Prescription · Approval201906847
  • MFDS drug아발린캡슐75밀리그램(프레가발린)2019-09-26
    Drug · Prescription · Approval201906857
  • MFDS drugLoxopron Tab. 60mg2019-09-20
    Drug · Prescription · Approval201906583
  • MFDS drugOmepran Cap. 20mg2019-09-19
    Drug · Prescription · Approval201906572
  • MFDS drug아포그릴정100밀리그램(사르포그렐레이트염산염)2019-09-11
    Drug · Prescription · Approval201906412
  • MFDS drugFamsyntex Tab. 250mg2019-09-02
    Drug · Prescription · Approval201906212
  • MFDS drugNT-funazol Cap. 50mg2019-08-23
    Drug · Prescription · Approval201905969
  • MFDS drugNT-xicam Cap. 7.5mg2019-08-05
    Drug · Prescription · Approval201905522
  • MFDS drugSyntec Clofenac Tab. 100mg2019-08-01
    Drug · Prescription · Approval201905471
  • MFDS drugAstraset Tab.2019-07-24
    Drug · Prescription · Approval201905261
  • MFDS drugAstraset-semi Tab.2019-07-24
    Drug · Prescription · Approval201905262
  • MFDS drugSyntex Cefaclor Cap.2018-06-26
    Drug · Prescription · Approval201802642
  • MFDS drugCellbion Isotonic Sodium Chloride for Injection2017-12-11
    Drug · Prescription · Notification201708287
  • MFDS drugDope tablet 5mg2017-10-20
    Drug · Prescription · Approval201707537
  • MFDS drugDope tablet 10mg2017-10-20
    Drug · Prescription · Approval201707538
  • MFDS drugSM Gel 5%Revoked2017-05-01
    Drug · OTC · Notification201702266
  • MFDS drugSM Gel 10.56%Revoked2017-04-26
    Drug · OTC · Approval201702115
  • MFDS drugSM Cream 10.56%2015-04-30
    Drug · OTC · Approval201502630
  • MFDS drugSM Cream 9.6%2008-11-10
    Drug · OTC · Notification200810888
  • MFDS drugCellbionMebrofenin for injection2006-11-20
    Drug · Prescription · Approval200611345
  • MFDS drugCellbionSestamibi for injection2001-02-15
    Drug · Prescription · Approval200100177
  • MFDS drugSM Gel 9.6%Revoked2000-12-28
    Drug · OTC · Notification200102064

Clinical trials

data.go.kr

6 MFDS clinical trial authorisations · 2016–2026 (Phase 1 3 · Phase 3 1 · Phase 1/2 1 · Phase 2 1)

  • Phase 3Lu-177-DGUL2026-09-28

    5 trial sites

  • Phase 1Lu-177-DGUL2025-09-12

    1 trial site

  • Phase 1/2Lu-177-DGUL2020-07-02

    5 trial sites

  • Phase 1Ga-68-NGUL2020-06-19

    1 trial site

  • Phase 199mTc-MSA2018-08-22

    1 trial site

  • Phase 2갈륨-68 노타-엠에스에이2016-08-04

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

Lu-177-Pocuvotide · 전립선암(PSMA 표적 Theranostics) · 국내 임상 2상 완료 · Selected as KDDF's 2023 top-10 national new drug project; designated orphan drug in development and GIFT program No. 11 by MFDS

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 9 more patents

AI reads

MAA server logs · IP-verified
70
Times AI engines pulled Cellbion Co., Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

68
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
57
live 2
Last 30 days
70
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot62
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Cellbion Co., Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition